Monoclonal antibodies that recognize the extracellular domain of the epidermal growth factor receptor (mAblO8) were conjugated with doxorubicin through a dextran bridge. Several antibody-drug conjugates, containing different amounts of doxorubicin, retained binding capacity to human epidermoid carcinoma (KB) cells overexpressing epidermal growth factor receptors. Slight decrease in drug cytotoxicity was seen in in vitro tests, as determined either by inhibition of thymidine incorporation into cells or by reduction in number and size of KB-cell colonies. Yet, when tested in vivo against KB tumor xenografted into nude mice, the antiepidermal growth factor-receptor drug conjugates with high drug-substitution levels were significantly more effective than free doxorubicin, antibody alone, mixture of dextran-doxorubicin and antibody, or drug conjugated with irrelevant antibody. When the labile covalent bonds linking antibody to dextran bridge were stabilized by reduction, the therapeutic efficacy ofthe conjugate was markedly decreased. These results show that antibodies against the extracellular domain of the epidermal growth factor can deliver doxorubicin specifically and efficiently to tumor sites that express high receptor levels exerting a specific antitumor effect. (8).In the present study we examine the possibility of enhancing the antitumor effect of mAblO8 by conjugating it to an antineoplastic drug, doxorubicin. The drug was conjugated by means of periodate-oxidized dextran to the antibodies. We had previously shown that daunorubicin'conjugated to antibodies against rat a-fetoprotein was very effective in prolonging the survival time of intraperitoneally hepatomachallenged rats (9). This work was recently successfully extended to subcutaneous hepatoma tumors that metastasize to the lungs with or without surgical resection of'the'subcutaneous tumor (10). We report here results showing high efficacy of doxorubicin-anti-EGF-receptor conjugates in the treatment of subcutaneous xenografts of human KB cells in nude mice. The specific conjugate was significantly more effective than free drug, drug linked to an irrelevant antibody, and various other pertinent controls.
MATERIALS AND METHODSAnimals. CD1 nude mice (aged 4-8 weeks) obtained from Charles River Breeding Laboratories were maintained at the Experimental Animals Center of the Weizmann Institute of Science.Cells. The KB human tumor cell line derived from oral epidermoid carcinoma was obtained from The American Type Culture Collection. Cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (depleted of complement activity), glutamine, penicillin, streptomycin, and sodium pyruvate, at 370C in 5% C02/95% air.Antibodies. The mAblO8 IgG2a hybridoma line was generated by immunizing mice with Chinese hamster ovary cells expressing the extracellular domain of the human EGF receptor (11). The mAb were purified as described (8).Binding of Antibody to Doxorubicin. mAblO8 or antidinitrophenyl (DNP) mAb were linked to doxoru...